Galectin Therapeutics Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary
Marketlines Galectin Therapeutics Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Galectin Therapeutics Inc. since January2007.
Synopsis
Marketlines Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Key Highlights
This report includes Galectin Therapeutics Inc.s contact information and business Summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Galectin Therapeutics Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Scope
- Provides intelligence on Galectin Therapeutics Inc.s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Galectin Therapeutics Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Galectin Therapeutics Inc.s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy
- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Galectin Therapeutics Inc.s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors business structure and growth strategies.
COMPANY OVERVIEW AND KEY FACTS
--Partnership - Deal reports
CAPITAL RAISING
--Capital Raising - Overview
--Capital Raising - Deal reports
--Private Equity and Ownership - Deal reports
APPENDIX
--About MarketLine Financial Deals Database
--Deal Definition and Methodology
--About MarketLine
--MarketLine Professional Services Knowledge Center
List Of Tables
--Galectin Therapeutics Inc. activity by deal type - volume (2013 -YTD2017)
--Galectin Therapeutics Inc. legal advisor ranking by value ($m)
--Top Deals(2013 -YTD2017)
--Galectin Therapeutics Inc. capital raising volume and value trend (2013-YTD2017)
--Galectin Therapeutics Inc. capital raising by deal type (2013-YTD2017)
List Of Figures
--Galectin Therapeutics Inc. activity by deal type - volume (2013-YTD2017)
--Galectin Therapeutics Inc. capital raising volume and value trend (2013-YTD2017)
--Galectin Therapeutics Inc. capital raising by deal type (2013-YTD2017)
Galectin 3 - Pipeline Review, H2 2019
Galectin 3 - Pipeline Review, H2 2019According to the recently published report Galectin 3 - Pipeline Review, H2 2019; Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or
USD 3500 View ReportGalectin Inhibitor -Pipeline Insight, 2019
Galectin Inhibitor - Pipeline Insight, 2019 report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Galectin Inhibitor development. The report
USD 1250 View ReportCesca Therapeutics Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Cesca Therapeutics Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines Cesca Therapeutics Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,
USD 350 View ReportAbeona Therapeutics Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Abeona Therapeutics Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines Abeona Therapeutics Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,
USD 350 View ReportFill The Form For Sample Request